Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
Boston ScientificBSX |
-$830,000 |
 |
MedtronicMDT |
-$290,000 |
 |
Edwards LifesciencesEW |
$81,000 |
 |
Intuitive SurgicalISRG |
$19,000 |
 |
Zimmer BiometZBH |
-$14,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Christine Smith Democrat | Nov 16, 2023 | Buy | $50K - $100K |
| Christine Smith Democrat | Nov 10, 2023 | Buy | $50K - $100K |
| Joshua Gottheimer Democrat | Jul 14, 2023 | Buy | $1K - $15K |
| Joshua Gottheimer Democrat | Jun 13, 2023 | Sell | $1K - $15K |
Who is the latest politician to buy or sell Artivion shares?
Christine Smith purchased Artivion shares most recently on November 16, 2023.
Which politician has bought the most AORT stock in the last two years?
Christine Smith has bought the most AORT stock in the last 2 years, with an estimated value of $150,000.
Which politician has sold the most AORT stock over the last two years?
Joshua Gottheimer has sold the most AORT stock in the last 2 years, with an estimated value of $8,000.
What is the total value of politicians trading AORT stock in the last 2 years?
According to our estimates, the net value of trades by US politicians for Artivion in the last 2 years is positive, amounting to $150,000. This indicates that US politicians have reasons to believe that the stock is going to go up.
How do insider transactions over the last 2 years reflect on Artivion's market confidence?
Over the last 2 years, insider transactions for Artivion have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
